ERASErasca, Inc.

$19.16

Who owns ERAS

223 institutions reported holding ERAS for 2026Q1, together 90% of the company, more than the 152 a quarter earlier.

223

Institutions reporting a position · as of 2026Q1 · up from 152 the quarter before

Shares held by institutions
273.5M

Shares held by institutions · 90% of the company · long US equity positions only, as reported on Form 13F

Reported value
$4.39B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
32%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
19
New positions
90
Positions exited
25
Added to
71
Reduced
39
Top 10 holdersof the company
52%
Institutional ownership by quarter, 2021Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q1223273.5M$4.39B
2025Q4152219.3M$816M
2025Q3139214.9M$468M
2025Q2141218.1M$277M
2025Q1153224.3M$307M
2024Q4145230.9M$579M
2024Q3131232.0M$633M
2024Q2124203.6M$480M
2024Q110872.7M$150M
2023Q411969.2M$148M
2023Q310971.3M$140M
2023Q211274.3M$205M
2023Q111778.0M$235M
2022Q410779.8M$344M
2022Q38880.5M$628M
2022Q28976.9M$428M
Largest reported holders, 2026Q1
HolderShares% of companyValue
Frazier Life Sciences Management, L.P.24.7M8.1%$399M
T. Rowe Price Investment Management, Inc.21.3M7.0%$344M
BlackRock Inc.20.2M6.6%$326M
Venrock Adviser, LLC16.4M5.4%$265M
RTW INVESTMENTS, LP16.2M5.3%$261M
VANGUARD GROUP INC14.9M4.9%$241M
Vivo Capital, LLC12.2M4.0%$197M
Siren, L.L.C.11.2M3.7%$182M
Logos Global Management LP11.2M3.7%$180M
Paradigm Biocapital Advisors LP10.4M3.4%$168M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…